MAPK1 and cancer: The overexpression of KIF2C in many cancers has led to proliferation, EMT activation, invasion, and metastasis via PI3K/AKT, mTORC1, and MAPK/ERK signaling (Mo et al., 2022; Huang et al., 2023; Liu et al., 2023).